post-bg-523
calendary October 5, 2023

Simplification of BMCP circulation

In March of this year, in our column dedicated to biomedical cell products (BMCP), we wrote about the planned changes in legislation regarding the circulation of BMCP. At the moment, the State Duma of the Russian Federation in the second and third readings has approved a law that approves circulation rules for BMCP.

The first significant change in the BMCP circulation is elimination of the legal uncertainty, which consists in the duality of the regulation of medical products that simultaneously comply with the definitions of the BMCP, and products subject to registration in accordance with the Decision of the EAEU No. 78. In this regard, after the entry into force of the new Federal Law, the articles of the Federal Law No. 180 will not apply to high-tech drugs subject to registration under the rules of the EAEU, and transplantation products.

In addition, registration of BMCP for individual use, manufactured for specific patients directly in the medical institutions in which the product was prescribed, will not be required. This provision will also apply to the so-called "academic" CAR-T preparations - T-lymphocytes modified in laboratories based on medical institutions (for more details about CAR-T therapy, see the articles in column "Biomedical cell product").

According to the information from the explanatory note to the draft law: “<...> the requirement for accreditation of medical organizations for the right to conduct clinical trials of biomedical cell products is also excluded as unclaimed and redundant due to the need to register these products from January 1, 2021 exclusively in accordance with the Rules for which this procedure is not provided.”

These changes are being made to “provide conditions for the innovative development of Russian medicine and healthcare in the context of restrictive actions of certain countries against the Russian Federation”.

The law, if approved by the Federation Council and signed by the President, will enter into force on April 1, 2024. Certain provisions of the document will begin to apply from January 1, 2026. The text of the law states that registration certificates for BMCP issued in accordance with No. 180-FZ will be valid until the end of their validity period, but no later than the end of December 2025.

References:
  1. https://sozd.duma.gov.ru/bill/289043-8#bh_note
  2. https://vademec.ru/news/%3E/news/2023/07/21/gosduma-prinyala-zakonoproekt-ob-obrashchenii-bmkp/
  3. https://pharmvestnik.ru/content/news/Gosduma-prinyala-zakon-o-vvoze-BMKP-bez-registracii.html

More related posts

new-img-1

Control

Fine for spa resort in Yessentuki

Roszdravnadzor has imposed a fine of 130 thousand rubles on a spa resort in Yessentuki for improper storage of medical products…

03.03.2016
READ ARTICLE
new-img-2

Roszdravnadzor

Roszdravnadzor – patients’ rights

In 2015, Roszdravnadzor restored the rights of more than 460 thousand citizens to effective, accessible, and safe medical…

03.03.2016
READ ARTICLE
new-img-3

Regulation

The certification scheme for medical products hasn’t changed recently

Roszdravnadzor informs that the certification scheme for products in the Russian Federation is determined by Decree of the…

03.04.2016
READ ARTICLE
new-img-4

Control

Fines – Rostov region

In one and a half months of 2016, the Local Agency of Roszdravnadzor in Rostov Region imposed fines of the total amount of…

03.10.2016
READ ARTICLE
new-img-5

Control

Unregistered medical products

Two citizens were fined for selling unregistered medicinal products on the Internet in the Republic of Bashkortostan.

03.10.2016
READ ARTICLE
new-img-6

Control

Unscheduled inspection by roszdravnadzor

Roszdravnadzor started an unscheduled inspection of the Federal State-Funded Institution of Sverdlovsk Region Kirovgrad Central…

03.14.2016
READ ARTICLE
new-img-7

Medical Devices

International medical device regulators forum (IMDRF)

The delegation of the Federal Service for Surveillance in Healthcare headed by Mikhail Murashko, Head of Roszdravnadzor,…

03.17.2016
READ ARTICLE
new-img-8

Pharmaceuticals

Roszdravnadzor has suspended a series of the preparation “Paratsetomol-UBF”

Roszdravnadzor has suspended a series of the preparation “Paratsetomol-UBF” in which pills the metal wire was found.

05.18.2016
READ ARTICLE
new-img-9

Roszdravnadzor

Medical equipment stands idle in the Pskov region

Roszdravnadzor (RZN) statement: the expensive medical equipment for the total amount of 342 million rubles stands idle in…

05.19.2016
READ ARTICLE
new-img-10

Control

Hospital control Jewish autonomous region

Roszdravnadzor has audited the activity of the Regional Budgetary Public Health Facility “Central district hospital of Lenin”…

05.20.2016
READ ARTICLE